| Expression pattern: |
UP |
| Associated gene: |
Wnt3a |
| Associated microRNA: |
hsa-miR-4726-3p, hsa-miR-4793-3p, hsa-miR-766-3p, hsa-miR-1343, hsa-miR-1226-5p |
| Biological function: |
Associated with capsular invasion in PTC; potential biomarker for progression. |
| Molecular mechanism: |
Predicted to act as a miRNA sponge (ceRNA-like). |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RNase R Treatment; RT-qPCR; divergent primers PCR; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Associated with capsular invasion; may be a putative biomarker for progression of PTC. |
| Description: |
chr12:129699809-129700698- (host gene TMEM132D) is up-regulated in PTC and correlates with capsular invasion, suggesting relevance to tumor progression. It is predicted to bind several miRNAs (e.g., miR-766-3p) consistent with a putative miRNA-sponge role. |
| Confidence score: |
0.6841 |